ESI-08

CAS: 301177-43-5

Ref. 3D-BMA17743

Produktinformation

• Name: ESI-08
• CAS: 301177-43-5

Beschreibung

ESI-08 is a drug that has been shown to have potent anti-cancer effects. It is a novel compound that inhibits the protein kinase AKT, which is an important mediator of the metabolic, proliferative, and survival pathways in mammalian cells. ESI-08 also has inhibitory activities on cardiac arrhythmia and cardiac hypertrophy. This drug colocalizes with mitochondria in cardiac cells, suggesting that it may be used as a mitochondrial targeting agent. ESI-08 has also been shown to have potent antagonistic effects against cancer cells, inhibiting their proliferation and inducing apoptosis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 353.5 g/mol
• Formel: C₂₀H₂₃N₃OS
• Reinheit: Min. 95%